Cannabics Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019
January 14, 2020 at 04:05 pm
Cannabics Pharmaceuticals Inc. announced earnings results for the first quarter ended November 30, 2019. For the first quarter, the company announced sales was USD 1,754 compared to USD 3,305 a year ago. Operating loss was USD 815,856 compared to USD 648,290 a year ago. Net loss was USD 5.142 million compared to USD 655,975 a year ago. Basic loss per share from continuing operations was USD 0.044 compared to USD 0.005 a year ago.